MEDINET Co., Ltd. (2370)

Market cap
¥7.9B
P/E ratio
-5.5x
Medinet develops cell processing and regenerative medicine products for hospitals and pharmaceutical companies, offering manufacturing services and facility operations.
Period EndCash from financing (Million JPY)YoY (%)
Sep 30, 2025-3-100.17%
Sep 30, 20241,461+26.19%
Sep 30, 20231,158-26.95%
Sep 30, 20221,585+46.43%
Sep 30, 20211,082-61.16%
Sep 30, 20202,787+2993.85%
Sep 30, 201990-91.89%
Sep 30, 20181,110+13.77%
Sep 30, 2017976+121.63%
Sep 30, 2016440+35.45%
Sep 30, 2015325-19.90%
Sep 30, 2014406
AI Chat